Seattle-based startup Navigating Cancer has raised $12 million for its digital platform that lets cancer doctors interact with their patients.… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More